The Ups and Downs: A Look at Bailard, Inc.'s Q4 2022 vs. Q1 2023 Investment Holdings
Ava Hoppe | 10 May, 2023
Bailard, Inc. recently released its 13F filings for Q4 2022 and Q1 2023, providing insight into the holdings of the investment management firm. The report details the changes in the number of shares held and the corresponding changes in value for various companies between the two quarters.
One of the biggest takeaways from the report is the significant increase in the number of shares held in the SPDR S&P 500 ETF TR (SPY) by 364.1%. This surge in holdings is accompanied by a considerable increase in the value of the shares held, rising from $18,400,000 in Q4 2022 to $85,402,000 in Q1 2023. It's worth noting that this investment follows the general trend of institutional investors moving toward index funds, particularly those that track the S&P 500.
The second most prominent change in holdings is for NVIDIA Corporation (NVDA). Despite the number of shares held remaining relatively consistent between the two quarters, the value of these shares increased by 84.5%, rising from $12,781,000 in Q4 2022 to $23,587,000 in Q1 2023.
Another notable change is the increase in the number of shares held in Advanced Micro Devices Inc (AMD) by 363.9%, accompanied by a corresponding increase in the value of shares held from $2,855,000 to $13,247,000. This surge in holdings is likely attributable to the company's ongoing success in the technology sector, with AMD being a significant player in the production of computer hardware.
However, not all changes are positive. Some companies experienced a decrease in holdings between the two quarters, with the most significant decline being for the SPDR Bloomberg Barclays Short Term Municipal Bond ETF (TFI) by 42.6%. The value of shares held in TFI also decreased significantly, falling from $88,563,000 in Q4 2022 to $50,856,000 in Q1 2023. It's unclear why Bailard, Inc. decided to reduce its holdings in this ETF, and it will be interesting to see if the trend continues moving forward.
Another company that experienced a notable decrease in holdings is Pfizer Inc (PFE), with the number of shares held decreasing by 4.9% and the value of shares held falling from $11,903,000 to $9,038,000. It's possible that this decrease in holdings is tied to emerging concerns about the efficacy of the company's COVID-19 vaccine, as well as other issues surrounding the pharmaceutical giant.
In conclusion, Bailard, Inc.'s Q4 2022 vs. Q1 2023 13F holdings comparison indicates a mix of positive and negative changes for various companies, providing valuable insight into the investment strategies of this institutional investor. While some companies experienced significant growth in the number of shares held and corresponding value, others saw a decline in holdings. Regardless, it's evident that Bailard, Inc. remains an active player in the investment market, making informed decisions based on the performance and future outlook of various companies.
Other Posts
- Analyzing Pacific Ridge Capital Partners' Q3-Q4 2022 13F Filing: Changes in Holdings and Investment Strategies
- Cider Mill Investments LP Q4 2018 vs. Q1 2019 13F Holdings Comparison
- Investing in Q1 2023: Comparing Boothe Investment Group's 13F Holdings to Q4 2022
- Generational Equity Advises Howell Service Corporation in Its Sale to Bronco Ventures
- Comparing Stonepine Capital's Q3 vs. Q4 13F Holdings: Winners and Losers
- Mastering the Forces of Attraction: How Master Magnetics' New Union Sparks Innovation
- Unveiling the Dynamics of Investment Strategy: How Kwmg, LLC Adapted in Early 2024
- Analyzing Barometer Capital Management Inc.'s Q3 vs. Q4 2022 13F Holdings Comparison
- PFM Health Sciences: Holdings Comparison Q3 2022 vs. Q4 2022
- Somerset Capital Management LLP Q2 2023 vs. Q3 2023 13F Holdings Comparison